John Libbey Eurotext



TREM-like transcript-1: at the frontier between haemostasis and inflammation Volume 17, issue 6, Novembre-Décembre 2011


See all figures

Groupe CHOC, Équipe Avenir Inserm, Faculté de médecine, université Henri-Poincaré, Nancy, France, Service de réanimation médicale, hôpital Central, CHU de Nancy, Nancy, France
  • Key words: TLT-1, platelet aggregation, inflammation
  • DOI : 10.1684/hma.2011.0661
  • Page(s) : 435-9
  • Published in: 2011

TLT-1 (TREM-Like Transcript-1) is a novel platelet membrane receptor which has been recently characterized and identified to play an important role in platelet biology. TLT-1 belongs to the Triggering Receptors Expressed on Myeloid cells (TREMs) family which includes several immunoreceptors expressed by innate immune cells. TLT-1 is exclusively expressed on megakaryocytes and platelets, sequestered in α-granules and rapidly brought to the surface of platelets upon activation. By linking fibrinogen and modulating calcium signaling, but also by displaying anti-inflammatory properties, TLT-1 appears to play an important role in maintaining vascular homeostasis, regulating both adhesion, aggregation and inflammation at sites of injury/infection. Recent evidences highlight that a better understanding of TLT-1 signaling and regulation, but also the capacity to modulate its activity, will certainly open new realistic therapeutic perspectives.